Genomic Profiling for
Better Cancer Care

Genomic Profiling for
Better Cancer Care

Cancer and
Precision Medicine

Cancer is caused by changes to important genes that control how our cells function. When a cell contains many mutated genes, it turns cancerous and multiplies uncontrollably into a tumor. Understanding the genetic changes present in a patient’s tumor provides more information for physicians to make the best decisions in each patient’s cancer care.

Selecting the Right
Treatment

Targeted therapy is a type of cancer treatment that uses drugs that target specific genetic mutations present in a patient’s tumor. These drugs can effectively interfere with the processes that cause cancer growth and development for better treatment outcomes.

Cancer cells adapt and mutate easily, which allows them to acquire resistance to treatment. Hence, after a period of initial treatment, the effectiveness of a treatment strategy may decrease. When this happens, the tumor may regrow. Through repeated testing, new mutations can be detected which allows physicians to optimize treatment plans promptly.

 

LIQUIK

We will soon be enrolling patients with Advanced Non-small Cell Lung Cancer for our clinical study that aims to examine how genomic profiles generated from liquid biopsy blood tests can complement conventional tissue-based testing.

Contact Us to find out more.

How It Works

The suitability of a test is discussed.

A blood sample is all obtained.

Gene mutations are detected and analyzed

Results and recommended therapies are detailed in a report

FAQ

What is genomic medicine?

No two people are the same, and neither are their cancers. Patients with the same type of cancer may not respond in the same way to the same treatment. Genomic medicine is a new medical approach that tailor healthcare to each person’s genetic make-up to improve treatment options and patient outcomes.

How does genomic testing work?

Our diagnostic tests are designed to profile cancer at the molecular level to match your cancer to the right treatment. It works by analyzing the DNA in cancer cells from a sample of your tumor to identify the genetic mutations driving its growth. This information will help physicians provide you with more personalized treatment such as targeted drugs based on the specific mutations in your tumor. We also have a test for the early detection of nasopharyngeal cancer before symptoms show. Additionally, our tests can check whether a person is predisposed to cancer by detecting genes commonly associated with increased risk of cancer.

What are the advantages of using genomic testing over traditional tests?

Our diagnostic tests provide a simpler and faster way to detect cancer mutations. All our tests require only one draw of blood compared to tissue biopsy, which requires surgically removing a piece of tissue from the body. The test turnaround time is also shorter with results coming back in days instead of over a week. This allows doctors to make more timely treatment decisions.

What types of cancers do your tests detect?

We specialize in the detection of cancers that are more common in Asia, which has the highest cancer death rates in the world. Our tests can target a broad range of cancers such as breast, colon, lung, pancreatic and nasopharyngeal cancers, among others.

Does the stage of cancer matter for your tests?

Our tests cover screening for early stage cancers to treatment selection for late stage cancers.

Need Help?